Indication
Treatment of opioid dependence within a framework of medical, social and psychological treatment. Treatment is intended for use in adults and adolescents aged 16 years or over.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Buvidal 128 MG Solucion Inyectable de Liberacion ProlongadaSpain · 128 mgMarketed
- Buvidal 16 MG Solucion Inyectable de Liberacion ProlongadaSpain · 16 mgMarketed
- BUVIDAL 160 mg SOLUCION INYECTABLE DE LIBERACION PROLONGADASpain · 160 mgAuthorised
- Buvidal 24 MG Solucion Inyectable de Liberacion ProlongadaSpain · 24 mgMarketed